This report presents a comprehensive analysis of the US infectious disease testing market, including:
• Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
• Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
• Ten-year test volume and sales forecasts for nearly 80 infectious disease testing performed in US hospitals, blood banks, physician offices, public health and commercial laboratories.
• Instrumentation technologies and feature comparison of leading analyzers.
• Sales and market shares of leading suppliers.
• Emerging diagnostic technologies and their potential market applications.
• Product development opportunities.
• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for suppliers.
Contains 1,037 pages and 177 tables

Table Of Contents

Table of Contents

Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. Creutzfeldt-Jakob’s Disease
a. Background
b. Diagnostic Tests
c. Vaccines
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
20. Cyclospora Cayetanensis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
e. Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
43. Microsporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
46. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
62. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
U.S.A.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
C. Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
c. Blood Banks
1) Community and Regional Centers
2) Plasma Fractionation Centers
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point of Care Testing
c. Other Decentralized Testing Locations
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako

List of Tables
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus
Tests
Major Companies Developing or Marketing Bartonella
Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida
Tests
Major Companies Developing or Marketing Chlamydia
Tests
Major Companies Developing or Marketing Clostridium
Tests
Major Companies Developing or Marketing Coronavirus
Tests
Major Companies Developing or Marketing Cryptosporidium
Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus
Tests
Major Companies Developing or Marketing Enterovirus
Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia
Tests
Major Companies Developing or Marketing Gonorrhea
Tests
Major Companies Developing or Marketing Hantavirus
Tests
Major Companies Developing or Marketing Helicobacter
Pylori Tests
Major Companies Developing or Marketing Hepatitis
Tests
Major Companies Developing or Marketing Herpes
Tests
Major Companies Developing or Marketing Influenza
Tests
Major Companies Developing or Marketing Legionella
Tests
Major Companies Developing or Marketing Lyme Disease
Tests
Major Companies Developing or Marketing Lymphogranuloma
Tests
Major Companies Developing or Marketing Malaria
Tests
Major Companies Developing or Marketing Measles
Tests
Major Companies Developing or Marketing Meningitis
Tests
Major Companies Developing or Marketing Microsporidium
Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma
Tests
Major Companies Developing or Marketing Papilloma
Virus Tests
Major Companies Developing or Marketing Parvovirus
Tests
Major Companies Developing or Marketing Pneumonia
Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus
Tests
Major Companies Developing or Marketing Rubella
Tests
Major Companies Developing or Marketing Salmonella
Tests
Major Companies Developing or Marketing Septicemia
Tests
Major Companies Developing or Marketing Shigella
Tests
Major Companies Developing or Marketing Staphylococci
Tests
Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing Syphilis
Tests
Major Companies Developing or Marketing Toxoplasmosis
Tests
Major Companies Developing or Marketing Trichomonas
Tests
Major Companies Developing or Marketing Tuberculosis
Tests
Major Companies Developing or Marketing West Nile
Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A. Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Laboratories Performing Infectious Disease Tests
by Market Segment
U.S.A.
Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
U.S.A.
Commercial/Private Laboratories Performing Infectious
Disease Tests by Annual Test Volume
U.S.A.
Physician Office Laboratories Performing Infectious
Disease Tests by Practice Size
U.S.A.
All Market Segments Infectious Disease Test Volume Forecast
U.S.A.
Hospital Laboratories Infectious Disease Test Volume Forecast
U.S.A.
Blood Banks Infectious Disease Test Volume Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Public Health Laboratories Infectious Disease Test
Volume Forecast
U.S.A.
All Market Segments Infectious Disease Diagnostics
Market Forecast
U.S.A.
Hospital Laboratories Infectious Disease Diagnostics
Market Forecast
U.S.A.
Blood Banks Infectious Disease Diagnostics Market Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Public Health Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
HIV or HIV I/HIV II Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HIVAg Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Western Blot/Other Confirmatory Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S.A.
Adenovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Aeromonads Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
BEA Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Blastocystis Hominis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Campylobacter Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Candida Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Clostridium Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Coronavirus Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
CoxsackieVirus Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Cryptosporidium Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Cyclospora Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
CMV Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
E. Coli Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Echovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Encephalitis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Enterovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
EBV Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Giardia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Granuloma Inguinale Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Hantavirus Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Helicobacter Pylori Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
HAV NAT Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
HBV NAT Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
HbsAg Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Hepatitis C Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Anti-HBC Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Anti-HBS Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Anti-HAV Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Hepatitis Delta Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HBcAg Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
HBeAg Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
ALT/SGPT Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Influenza Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Legionella Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Lyme Disease Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Lymphogranuloma Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Malaria Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Measles Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Meningitis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Microsporidium Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Mononucleosis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Mumps Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Mycoplasma Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Papilloma Virus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.s.a.
Parvovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Pneumonia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Polyomaviruses Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Pseudomonas Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Rabies
Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
RSV Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Rhinovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Rotavirus Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Rubella Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Salmonella Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Septicemia Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Shigella Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Staphylococci Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Streptococci Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Trichomonas Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Tuberculosis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Vibrio Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
West Nile Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Yersinia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
AIDS Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Adenovirus Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Campylobacter Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Candida Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Chancroid Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Chlamydia Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
CMV Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Cryptosporidium Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Echovirus Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Enterovirus Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
EBV Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Giardia Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Gonorrhea Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Helicobacter Pylori Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Hepatitis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Hepatitis C Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Herpes Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Influenza Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Legionella Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Lyme Disease Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Measles Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Meningitis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Mononucleosis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Mumps Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Mycoplasma Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Pneumonia Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Rabies Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
RSV Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Rotavirus Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Rubella Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Salmonella Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Septicemia Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Shigella Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Streptococci Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Syphilis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Toxoplasmosis Testing Market Diagnostics Sales
by Major Supplier

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...

Analysis of the Global In Vitro Diagnostics Market

Analysis of the Global In Vitro Diagnostics Market

  • $ 10 000
  • Industry report
  • July 2014
  • by Frost & Sullivan

Slowing US and European Markets Demand Alignment with Global Market Needs Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.